Design Template
17-18 November 2014 | Marriott Grosvenor


FT Live Financial Times Live, the global conferences and events arm of the Financial Times, gathers pre-eminent public and private sector decision-makers, visionaries and strategists from the world’s most important economies and industries for a wide range of interactive, agenda-setting programmes that combine the power of on-site discussion and networking with the flexibility of live-streamed and on-demand broadcasting.

Chaired by senior journalists from the Financial Times and its group publications, the summits, conferences, awards and strategic forums organised by FT Live provide audiences with the opportunity to listen to and interact with speakers of the highest calibre in lively and stimulating debates that cover the key issues of our time.

The Financial Times provides essential news, comment, data and analysis for the global business community. It has a combined print and online average daily readership of 2.1 million people worldwide and a combined paid print and digital circulation of almost 629,000 (Deloitte assured, Q3 2013). FT education products now serve 34 of the world’s top 50 business schools.



Deloitte’s life sciences and health care (LSHC) industry group is composed of more than 7,300 professionals in over 70 countries. These professionals understand the complexity of today’s life sciences and health care industry challenges, and provide clients with integrated, comprehensive services that meet their respective needs. In today’s environment, LSHC professionals from across the Deloitte network help companies to evolve in a changing marketplace, pursue new and innovative solutions, and sustain long-term profitability.



Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics and benchmarks. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study planning to study conduct, from site engagement to patient engagement. We are committed to advancing the competitive and scientific goals of our global customers, which include over 95% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organisations.


Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services.  With a network of more than 30,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s Top 100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes.



Wipro Ltd. (NYSE:WIT) is a leading Information Technology, Consulting and Outsourcing company that delivers solutions to enable its clients do business better. Wipro delivers winning business outcomes through its deep industry experience and a 360 degree view of "Business through Technology" - helping clients create successful and adaptive businesses. A company recognized globally for its comprehensive portfolio of services, a practitioner's approach to delivering innovation, and an organization wide commitment to sustainability, Wipro has a workforce of 140,000 serving clients across 57 countries.


Linklaters is a leading international law firm with offices in all of the world’s leading financial and business centres and Healthcare specialists are present in most of our offices. Our international footprint is further extended by the sector expertise at our alliance partner firms. This international, cross practice reach and our extensive experience in the industry means that we have a clear understanding of the constantly evolving challenges faced by businesses operating in this sector. Our work includes M&A and finance projects and commercial matters, both contentious and non-contentious. Our clients include leading players from the pharmaceutical, biotech, medical devices, healthcare service groups, banks, private equity houses and private hospitals, insurance and services fields, as well as the healthcare teams at investment banks, private equity firms, and sovereign wealth funds.


Lloyds Bank Commercial Banking provides comprehensive expert financial services to businesses of all sizes, from start ups, through to small businesses, mid-sized businesses and multinational corporations. These clients range from privately-owned firms to FTSE 100 plcs, global corporations and financial institutions.  

Maintaining a network of relationship teams across the UK, as well as internationally, Lloyds Bank Commercial Banking delivers the mix of local understanding and global expertise necessary to provide long-term support and advice to its clients.  
Lloyds Bank Commercial Banking offers a broad range of finance beyond just term lending and this spans import and export trade finance, structured and asset finance, securitisation facilities and capital market funding. Its product specialists provide bespoke financial solutions including tailored cash management, international trade, treasury and risk management services. 

Lloyds Bank has been voted Bank of the Year for an unprecedented nine consecutive years at the FDs’ Excellence Awards in association with ICAEW and supported by the CBI & Real Business.


The Clinical Research Network is part of the National Institute for Health Research. We provide researchers with the practical support they need to make clinical studies happen in the NHS, so that more research takes place across England, and more patients can take part. It provides:

A single point of contact and entry for all services
Study and protocol feasibility from key opinion leaders and active commercial researchers
Access to the NIHR Coordinated System for gaining NHS Permission (NIHR CSP) for R&D approvals
Support with study start up processes and contract negotiations, using standard templates
Dedicated and trained Research Network resources to support study delivery at site level (staff and support services)
Performance management of the study in partnership with the company
Clinical Research Network ‘badging’ of adopted trials to attract both investigators and patients